Galectin Therapeutics Inc. (GALT) vs Century Therapeutics, Inc. (IPSC)
A side-by-side comparison of Galectin Therapeutics Inc. and Century Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GALT
Galectin Therapeutics Inc.
$3.70HealthcareDelayed quote: Oct 6, 2026, 3:19 PM EDT
IPSC
Century Therapeutics, Inc.
$1.36HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
Total return — GALT vs IPSC
growth of $100 · dividends reinvested · last 5yGALT -0.5% (-0.1%/yr)IPSC -93.5% (-42.1%/yr)GALT compounded faster over this window
Log scale — wide-divergence pair
GALT IPSC
GALT vs IPSC: by the numbers
- •IPSC is the larger company ($245M vs $244M market cap).
- •Both run net losses; GALT's is the smaller (0.00% vs -8.78% net margin).
Metrics side by side
Valuation
| Metric | GALT | IPSC |
|---|---|---|
| P/B ratio | N/A | 1.06 |
Profitability
| Metric | GALT | IPSC |
|---|---|---|
| Gross margin | 0.00% | 88.00% |
| Operating margin | 0.00% | -13.78% |
| Net margin | 0.00% | -8.78% |
| ROE | N/A | -47.25% |
| ROIC | -1718.59% | -43.69% |
Growth (annualized)
| Metric | GALT | IPSC |
|---|---|---|
| Total return CAGR (5Y) | 0.60% | -42.05% |
Frequently asked
- How have GALT and IPSC total returns compared?
- Over the past 5 years, GALT delivered 0.60% and IPSC delivered -42.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Galectin Therapeutics ROECentury Therapeutics ROEGalectin Therapeutics operating marginCentury Therapeutics operating marginGalectin Therapeutics revenue growthCentury Therapeutics revenue growthGalectin Therapeutics free cash flowCentury Therapeutics free cash flow
Galectin Therapeutics & Century Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.